Authors
Renjie Huang, Miao Huang, Rui Zhang
Published in
American journal of hypertension. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
The association between a newly reported major diagnosis and subsequent self-reported hypertension-treatment status remains uncertain.
We analyzed seven overlapping periods of three visits approximately 2 years apart in the Korean Longitudinal Study of Ageing (2006-2008-2010 through 2018-2020-2022). Eligibility required age ≥50 years, physician-diagnosed hypertension at Visit 1, and reported antihypertensive medication use or hypertension treatment at Visits 1 and 2. Newly reported diabetes, cancer, stroke, heart disease, or chronic lung disease was assessed at Visit 2. The Visit 3 outcome was a report of no current hypertension treatment, including no antihypertensive medication use. Modified-Poisson regression used participant-clustered standard errors. The adjusted absolute risk difference was defined as the standardized probability with a newly reported diagnosis minus that without one.
Among 13,579 observation periods from 3,581 participants, 932 included a newly reported diagnosis. Adjusted probabilities of no reported treatment were 7.5% with and 8.4% without a newly reported diagnosis. The adjusted risk ratio for not receiving treatment for hypertension, including antihypertensive medication, associated with a newly reported diagnosis was 0.89 (95% confidence interval 0.71-1.13); the adjusted absolute risk difference (newly reported diagnosis minus no newly reported diagnosis) was -0.90 percentage points (95% confidence interval -2.66 to 0.85).
A newly reported major diagnosis was not associated with self-reported antihypertensive medication use or hypertension treatment approximately 2 years later.
PMID:
43009185
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0